Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma
SPRING, Texas, Dec. 06, 2025 (Korea Bizwire) – Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today collaborative presentations at the 67th American Society of Hematology Annual Meeting and Exposition, in Orlando, Florida; with scientists from the Duke University School of Medicine in Durham, North Carolina; reporting data from preclinical studies [...]





![[UPDATE] The Politecnico di Milano inaugurates its 163rd academic year, emphasising responsibility, scientific diplomacy and collaboration in Europe [UPDATE] The Politecnico di Milano inaugurates its 163rd academic year, emphasising responsibility, scientific diplomacy and collaboration in Europe](http://koreabizwire.com/wp/wp-content/uploads/2025/12/bo1a0881-54956449927-o-2.jpg)




